Esteban G. Burchard, MD, MPH
|School||UCSF School of Pharmacy|
|Address||1550 4th Street, Bldg 19B|
San Francisco CA 94158
|University of California, Berkeley||M.P.H. Epidemiology||2006||Public Health|
|University of California, San Francisco||Pulmonary and Critical Care Medicine||2001||Medicine|
|Brigham and Women's Hospital||Internal Medicine Residency||1998||Medicine|
|Harvard University School of Public Health||Certificate, Clinical Effectiveness||1997||School of Public Health|
|Stanford University School of Medicine||M.D.||1995||Medicine|
|San Francisco State University||B.S. Cellular and Molecular Biology||1990||Biology|
|2015||Precision Medicine Initiative, Advisory Committee to the Director|
|2015||National Academy of Sciences, Engineering and Medicine, Committee on Incorporating 21st Century Scie|
|2013||Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II|
|2013||Guest Speaker, Smithsonian Institution National Museum of Natural History (NMNH), Washington D.C.|
|2012||American Museum of Natural History (AMNH) Documentary featuring our research. New York City |
|2011||Athletic Hall of Fame, San Francisco State University|
|2010||Guest Speaker, NPR’s Science Friday, hosted by Ira Flatow|
|2009||American Society of Clinical Investigation (ASCI), inducted member |
|2009||Guest Speaker, Tavis Smiley Show |
|2008||NIH Study Section Member, Genetics of Health and Disease (GHD) |
||2010||RWJ Amos Medical Faculty Development Award|
|San Francisco State University||1988
||1989||National Collegiate Athletic Association (NCAA) Div. II Academic All-American, Wrestling|
|1987||California State Espoir Freestyle Wrestling Finalist, 2nd place finish |
Asthma is the most common chronic disease among children. In the U.S., childhood asthma prevalence is highest among Puerto Ricans (18.4%), followed by Blacks (14.6%), Whites (8.2%) and Mexicans (4.8%). These disparities extend to asthma mortality, which is four-fold higher in Puerto Ricans and African Americans compared to Mexican Americans. There are marked differences in drug response to asthma therapies between racial and ethnic groups, which contribute to health disparities in asthma morbidity and mortality. Albuterol, a short-acting ß2-agonist, is the most commonly prescribed asthma medication in the world. We and others have demonstrated that Puerto Rican and African American children with asthma were significantly less responsive to albuterol than European American children. In addition, long-acting ß2-agonist (LABA) usage has been associated with increased mortality among African American subjects. These findings suggest that poor response to asthma therapies contributes to health disparities in asthma morbidity and mortality. Racial/ethnic differences in drug response are partially explained by genetic differences. We study the interplay between genes and the environment to determine the root causes of asthma health disparities in children and adolescents to identify and develop targeted interventions to improve asthma outcomes.
I work in collaboration with a multi-disciplinary team of investigators from several Universities, which includes scientists with expertise in epidemiology, biostatistics, medicine, molecular and cell biology and genomics. Using tools from these disciplines, we perform comprehensive research (genetic, social and environmental) designed to untangle why populations differ in health and disease. We have leveraged the rich ancestry of racially mixed (admixed) populations to untangle complex gene-environment interactions for health and disease. We have developed specific expertise in population-based genetic studies in admixed populations. Most importantly, we are working to ensure that modern advances in research will benefit all populations.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.